Description
从实验室到临床，干细胞治疗为全球数千万自闭症家庭带来新希望。2025年8月11日，日本厚生劳动省正式批准了Biostar研究所的“天使干细胞疗法”用于自闭症谱系障碍（ASD）治疗。这是全球首个获得国家级药监部门批准的自闭症干细胞治疗方案，标志着再生医学在神经发育障碍领域取得重大突破。自闭症谱系障碍患者及其家庭，迎来了一个全新的治疗选择。
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast